Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 18, 2014
 
Register | Sign in
Home Page > White Papers
  White Papers
Scientific News
Gene Linked to Excess Male Hormones in Female Infertility Disorder
Discovery by NIH-supported researchers may lead to diagnostic test, treatment.
How a Silly Putty Ingredient Could Advance Stem Cell Therapies
The sponginess of the environment where human embryonic stem cells are growing affects the type of specialized cells they eventually become.
Domainex Programme Shows Great Promise for the Treatment of Inflammatory Diseases
Company’s IKKe/TBK1 programme to offer a disease-modifying treatment for COPD patients.
Nanocrystalline Cellulose Modified into an Efficient Viral Inhibitor
Researchers have succeeded in creating a surface on nano-sized cellulose crystals that imitates a biological structure.
Drug Does Not Improve Set of Cardiovascular Outcomes for Diastolic Heart Failure
NIH-supported study finds drug does appear to reduce hospitalizations for diastolic heart failure.
Will Forensic Biology Become Forensic Molecular Biology?
The article presents some examples of the potential for new molecular biology technologies to assist in the investigation of crime.
Lab Scale Manufacturing Using Continuous Crystallization
A new METTLER TOLEDO On-demand webinar explores recent research that could revolutionize pharmaceutical production.
Unexpected Protein Partnership has Implications for Cancer Treatment
Scientists have identified a macrophage that works together in response to cancer drugs to increase inflammation in a way that may alter tumor growth.
Targeting Cancer with a Triple Threat
MIT chemists design nanoparticles that can deliver three cancer drugs at a time.
Fluorescent Sensor Detects Date Rape Drug Within Seconds
The sensor, developed by researchers from the National University of Singapore (NUS), identifies the presence of GHB, a drug known commonly used to spike beverages.
Scroll Up
Scroll Down

A Scientific Approach to Good Manufacturing Practices
Bookmark and Share
AMRI


For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



AMRI to Acquire Cedarburg Pharmaceuticals, Inc.
Broadens contract development and manufacturing capabilities with high value, complex API business.
Friday, March 28, 2014
AMRI Announces Senior Level Leadership Appointment
The appointment of Michael A. Luther, Ph.D. as Senior Vice President of Discovery sees AMRI expanding its biology capabilities.
Thursday, October 17, 2013
AMRI Awarded Contract from the UK Government
Seven-year contract awarded for the development and manufacture of an active ingredient under clinical evaluation.
Thursday, October 03, 2013
FDA Performs Re-inspection of AMRI Burlington MA Facility
Issues Form 483 for three inspectional observations.
Friday, July 26, 2013
AMRI Burlington Receives DEA Approval to Handle Controlled Substances
Approval to handle Schedule 2 and 2N controlled substances at this location further supports AMRI SMARTSOURCING™ offering.
Wednesday, June 19, 2013
AMRI Promotes Susan Collins to Director, Business Development
Ms. Collins is responsible for leading AMRI’s North American Discovery Business Development team.
Tuesday, June 18, 2013
AMRI Announces Appointment of Chairman of the Board of Directors
Company has appointed William S. Marth as Chairman of the Board, effective June 5, 2013.
Friday, June 07, 2013
AMRI and Ono Broaden SMARTSOURCING™ Collaboration
New agreement extends drug discovery and development collaboration between the companies.
Friday, April 26, 2013
AMRI Announces the Promotion of Richard Saffee
Company promotes Mr. Saffee to Vice President and General Manager of large scale manufacturing.
Wednesday, January 09, 2013
AMRI Announces Five-Year Extension of API Supply Agreement with Shire
AMRI enters into a multi-year supply agreement for an undisclosed product.
Tuesday, October 23, 2012
AMRI Promotes Daniel Conlon to Senior Director of Business Development
Conlon will lead AMRI’s development and manufacturing services sales team for North America.
Wednesday, September 12, 2012
AMRI Further Expands Discovery Capabilities in India
Two strategic hires bring additional flexibility to global drug discovery operations.
Thursday, June 21, 2012
AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited
AMRI to further develop and manufacture the influenza antiviral CS8958.
Thursday, April 19, 2012
AMRI Signs Exclusive Option to License its Tubulin Inhibitor Program for Cancer
Agreement demonstrates AMRI’s commitment to value creation from its proprietary portfolio of compounds and programs.
Friday, April 06, 2012
AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC
AMRI will anchor small molecule discovery and CMC services.
Monday, February 13, 2012
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv